{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:40:28Z","timestamp":1787614828430,"version":"build-2736575974"},"reference-count":71,"publisher":"Ubiquity Press, Ltd.","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["gh"],"abstract":"<jats:p>Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the definition of HF and its antecedent stages have limited research, global surveillance, and prevention programs. To address this, several cardiac societies and foundations convened to standardize the definition of HF in 2021 and designated stage B or pre-HF to identify individuals at risk of developing HF. In subsequent years, substantial progress and changes have been made in aspects of preventing HF, improving HF diagnosis and management, and recognizing the importance of the affected individual\u2019s voice. Global differences and disparities in HF are better understood, as are causes and comorbidities leading to differences in care, which are also influenced by access to care. This consensus document presents the Second Universal Definition of Heart Failure, aiming to standardize terminology and facilitate a uniform approach for clinicians, researchers, health systems, and policymakers. In this definition, the classification of HF phenotypes moves away from rigid left ventricular ejection fraction cutoffs, instead grouping HF into reduced, preserved, and improved ejection fraction categories to better reflect clinical realities. A universal classification of HF causes is also proposed. The document also addresses the dynamic trajectories of HF\u2014improvement, remission, and recovery\u2014and highlights the impact of social determinants and geographic variation on HF risk and outcomes. By providing a comprehensive, standardized framework for HF definition and classification, this document seeks to improve prevention, early detection, and management of HF worldwide, ultimately enhancing patient care and advancing global cardiovascular health.<\/jats:p>","DOI":"10.5334\/gh.1569","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:53:01Z","timestamp":1782733981000},"page":"51","source":"Crossref","is-referenced-by-count":1,"title":["AHA\/ACC\/ESC\/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)"],"prefix":"10.5334","volume":"21","author":[{"given":"Mary Norine","family":"Walsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Kober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Sliwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Adamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anubha","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitava","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biykem","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Cikes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albertino","family":"Damasceno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay S.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Michael","family":"Felker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Kittleson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.P.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Mcdonagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Mullens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Luiz P.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Vaughn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Vest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Ton behalf of the Joint American Heart Association (AHA)\/American College of Cardiology (ACC)\/European Society of Cardiology (ESC)\/World Heart Federation (WHF) Task Force for the Universal Definition of Heart Failure in collaboration with the Heart Failure Society of America (HFSA), the Heart Failure Association (HFA) of the European Society of Cardiology, and the Japanese Heart Failure Society (JHFS)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"key20260629115258_B1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","article-title":"Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure","volume":"27","year":"2021","journal-title":"J Card Fail"},{"key":"key20260629115258_B2","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cardfail.2023.07.006","article-title":"Heart failure epidemiology and outcomes statistics: a report of the Heart Failure Society of America","volume":"29","year":"2023","journal-title":"J Card Fail"},{"key":"key20260629115258_B3","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jacc.2012.12.038","article-title":"Heart failure\u2013associated hospitalizations in the United States","volume":"61","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key20260629115258_B4","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0140-6736(25)01393-5","article-title":"Prioritising the primary prevention of heart failure","volume":"406","year":"2025","journal-title":"Lancet"},{"key":"key20260629115258_B5","first-page":"e275","article-title":"2026 Heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"153","year":"2026","journal-title":"Circulation"},{"key":"key20260629115258_B6","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.jacc.2021.06.058","article-title":"Race and ethnicity in heart failure","volume":"78","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"key20260629115258_B7","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/eurheartj\/ehac103","article-title":"Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction","volume":"43","year":"2022","journal-title":"Eur Heart J"},{"key":"key20260629115258_B8","article-title":"Fourth Universal Definition of Myocardial Infarction (2018) [published correction appears in Circulation. 2024;149:e1164]","volume":"138","author":"the Executive Group on behalf of the Joint European Society of Cardiology (ESC)\/American College of Cardiology (ACC)\/American Heart Association (AHA)\/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction","year":"2018","journal-title":"Circulation"},{"key":"key20260629115258_B9","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"ESC Scientific Document Group","year":"2021","journal-title":"Eur Heart J"},{"key":"key20260629115258_B10","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","year":"2022","journal-title":"Circulation"},{"key":"key20260629115258_B11","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.amjcard.2012.05.014","article-title":"Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction","volume":"110","year":"2012","journal-title":"Am J Cardiol"},{"key":"key20260629115258_B12","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/eurheartj\/ehab911","article-title":"Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality","volume":"43","year":"2022","journal-title":"Eur Heart J"},{"key":"key20260629115258_B13","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jcmg.2015.02.014","article-title":"Ethnic-specific normative reference values for echocardiographic LA and LV size, LV mass, and systolic function: the EchoNoRMAL study","volume":"8","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"key20260629115258_B14","first-page":"1027","article-title":"Pre-heart failure: an important opportunity to prevent a deadly disease","volume":"11","year":"2023","journal-title":"JACC Heart Fail"},{"key":"key20260629115258_B15","article-title":"Preventing new-onset heart failure: intervening at stage A","volume":"16","year":"2023","journal-title":"Am J Prev Cardiol"},{"key":"key20260629115258_B16","article-title":"Prevalence and mortality of heart failure stages in a free-living older adult population: data from the Brazilian Longitudinal Study of Adult Health","volume":"14","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"key20260629115258_B17","article-title":"Predicting and preventing heart failure","volume":"3","year":"2024","journal-title":"Considerations Med"},{"key":"key20260629115258_B18","first-page":"e841","article-title":"Addressing social determinants of health in the care of patients with heart failure: a scientific statement from the American Heart Association","volume":"141","author":"on behalf of the American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Epidemiology and Prevention","year":"2020","journal-title":"Circulation"},{"key":"key20260629115258_B19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/ehjqcco\/qcy047","article-title":"Impact of socioeconomic status on incident heart failure and left ventricular dysfunction: systematic review and meta-analysis","volume":"5","year":"2019","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"key20260629115258_B20","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/S2214-109X(19)30484-X","article-title":"Trends in cardiometabolic risk factors in the Americas between 1980 and 2014: a pooled analysis of population-based surveys","volume":"8","year":"2020","journal-title":"Lancet Glob Health"},{"key":"key20260629115258_B21","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/s41569-024-01058-2","article-title":"Epidemiology of cardiometabolic health in Latin America and strategies to address disparities","volume":"21","year":"2024","journal-title":"Nat Rev Cardiol"},{"issue":"suppl 1","key":"key20260629115258_B22","first-page":"S13","article-title":"New strategies and therapies for the prevention of heart failure in high-risk patients","volume":"45","year":"2022","journal-title":"Clin Cardiol"},{"key":"key20260629115258_B23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association\u2019s strategic Impact Goal through 2020 and beyond","volume":"121","author":"on behalf of the American Heart Association Strategic Planning Task Force and Statistics Committee","year":"2010","journal-title":"Circulation"},{"key":"key20260629115258_B24","first-page":"e18","article-title":"Life\u2019s Essential 8: updating and enhancing the American Heart Association\u2019s construct of cardiovascular health: a presidential advisory from the American Heart Association","volume":"146","author":"on behalf of the American Heart Association","year":"2022","journal-title":"Circulation"},{"key":"key20260629115258_B25","article-title":"An opportunity for prevention: associations between the Life\u2019s Essential 8 score and cardiovascular incidence using prospective data from UK Biobank","volume":"48","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"key20260629115258_B26","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/eurheartj\/ehv728","article-title":"Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME\u00ae trial","volume":"37","author":"EMPA-REG OUTCOME\u00ae Trial Investigators","year":"2016","journal-title":"Eur Heart J"},{"key":"key20260629115258_B27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCULATIONAHA.121.057983","article-title":"Finerenone reduces risk of incident heart failure in patients with chronic kidney disease and type 2 diabetes: analyses from the FIGARO-DKD trial","volume":"145","author":"FIGARO-DKD Investigators","year":"2022","journal-title":"Circulation"},{"key":"key20260629115258_B28","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"SELECT Trial Investigators","year":"2023","journal-title":"N Engl J Med"},{"key":"key20260629115258_B29","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","author":"SOLVD Investigators","year":"1992","journal-title":"N Engl J Med"},{"key":"key20260629115258_B30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.2013.7588","article-title":"Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"key20260629115258_B31","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jacc.2013.05.069","article-title":"PONTIAC (NT-proBNP Selected Prevention of Cardiac Events in a Population of Diabetic Patients Without a History of Cardiac Disease): a prospective randomized controlled trial","volume":"62","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key20260629115258_B32","first-page":"270","article-title":"Albuminuria and heart failure: JACC state-of-the-art review","volume":"81","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"key20260629115258_B33","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1001\/jama.2010.1708","article-title":"Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults","volume":"304","year":"2010","journal-title":"JAMA"},{"key":"key20260629115258_B34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41591-018-0240-2","article-title":"Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram","volume":"25","year":"2019","journal-title":"Nat Med"},{"key":"key20260629115258_B35","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/CIRCULATIONAHA.122.062646","article-title":"Detection of left ventricular systolic dysfunction from electrocardiographic images","volume":"148","year":"2023","journal-title":"Circulation"},{"key":"key20260629115258_B36","article-title":"Multinational clinical and community-based validation of PRESENT-SHD, an ensemble deep learning approach for the detection of multiple structural heart disorders using electrocardiographic images","volume":"150","year":"2024","journal-title":"Circulation"},{"key":"key20260629115258_B37","article-title":"Artificial intelligence enabled prediction of heart failure risk from single-lead electrocardiograms","journal-title":"medRxiv"},{"key":"key20260629115258_B38","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/ejhf.1776","article-title":"Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure","volume":"22","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"key20260629115258_B39","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/eurheartj\/ehaa158","article-title":"Time to rename the middle child of heart failure: heart failure with mildly reduced ejection fraction","volume":"41","year":"2020","journal-title":"Eur Heart J"},{"key":"key20260629115258_B40","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/ejhf.1325","article-title":"Redefining heart failure phenotypes based on ejection fraction","volume":"20","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"key20260629115258_B41","article-title":"What is a normal left ventricular ejection fraction in healthy adults? A meta-analysis of population-based echocardiographic studies","volume":"34","year":"2026","journal-title":"J Cardiovasc Imaging"},{"key":"key20260629115258_B42","article-title":"Toward a universal definition of etiologies in heart failure: categorizing causes and advancing registry science","volume":"17","author":"Global Heart Failure Roundtable Group","year":"2024","journal-title":"Circ Heart Fail"},{"key":"key20260629115258_B43","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ejhf.2417","article-title":"A population-based study of 92 clinically recognized risk factors for heart failure: co-occurrence, prognosis and preventive potential","volume":"24","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"key20260629115258_B44","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies","volume":"93","year":"1996","journal-title":"Circulation"},{"key":"key20260629115258_B45","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","article-title":"Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention","volume":"113","author":"on behalf of the American Heart Association","year":"2006","journal-title":"Circulation"},{"key":"key20260629115258_B46","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"ESC Scientific Document Group","year":"2023","journal-title":"Eur Heart J"},{"key":"key20260629115258_B47","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.jacc.2013.08.1644","article-title":"The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation","volume":"62","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key20260629115258_B48","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/eurheartj\/ehaa084","article-title":"Heart failure can affect everyone: the ESC Geoffrey Rose lecture","volume":"41","year":"2020","journal-title":"Eur Heart J"},{"key":"key20260629115258_B49","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/CIRCULATIONAHA.114.008720","article-title":"Global and regional patterns in cardiovascular mortality from 1990 to 2013","volume":"132","year":"2015","journal-title":"Circulation"},{"key":"key20260629115258_B50","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ijcard.2017.11.084","article-title":"The impact of migration on cardiovascular diseases","volume":"254","year":"2018","journal-title":"Int J Cardiol"},{"key":"key20260629115258_B51","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1161\/CIRCULATIONAHA.108.786244","article-title":"Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities","volume":"118","year":"2008","journal-title":"Circulation"},{"key":"key20260629115258_B52","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/eurjhf\/hft061","article-title":"A predominance of hypertensive heart failure in the Abuja Heart Study cohort of urban Nigerians: a prospective clinical registry of 1515 de novo cases","volume":"15","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"key20260629115258_B53","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ijcard.2012.11.065","article-title":"Worldwide risk factors for heart failure: a systematic review and pooled analysis","volume":"168","year":"2013","journal-title":"Int J Cardiol"},{"key":"key20260629115258_B54","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/eurjpc\/zwaa147","article-title":"Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017","volume":"28","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"key20260629115258_B55","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/ejhf.1585","article-title":"Heart failure around the world","volume":"21","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"key20260629115258_B56","article-title":"Sub-Saharan Africa\u2019s contribution to clinical trials in international acute coronary syndromes and heart failure guidelines","volume":"3","year":"2024","journal-title":"JACC Adv"},{"key":"key20260629115258_B57","article-title":"Heart failure improvement, remission, and recovery: a European Journal of Heart Failure expert consensus document","journal-title":"Eur J Heart Fail"},{"key":"key20260629115258_B58","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jacc.2022.11.023","article-title":"Worsening heart failure: nomenclature, epidemiology, and future directions: JACC review topic of the week","volume":"81","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"key20260629115258_B59","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ejhf.2874","article-title":"Worsening of chronic heart failure: definition, epidemiology, management and prevention: a clinical consensus statement by the Heart Failure Association of the European Society of Cardiology","volume":"25","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"key20260629115258_B60","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/ejhf.2607","article-title":"Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial","volume":"24","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"key20260629115258_B61","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/ejhf.2887","article-title":"Incremental prognostic value of biomarkers in PARADIGM-HF","volume":"25","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"key20260629115258_B62","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jacc.2023.11.030","article-title":"Implantable hemodynamic monitors improve survival in patients with heart failure and reduced ejection fraction","volume":"83","author":"GUIDE-HF, CHAMPION, and LAPTOP-HF Investigators","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"key20260629115258_B63","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jchf.2023.06.001","article-title":"Differentiation between worsening heart failure and decompensated heart failure","volume":"11","year":"2023","journal-title":"JACC Heart Fail"},{"key":"key20260629115258_B64","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jchf.2023.02.001","article-title":"Proposed new conceptualization for definition of decompensated HF: taking the acute out of decompensation","volume":"11","year":"2023","journal-title":"JACC Heart Fail"},{"key":"key20260629115258_B65","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction: Trandolapril Cardiac Evaluation (TRACE) Study Group","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"key20260629115258_B66","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0735-1097(96)00489-5","article-title":"Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study: SAVE Investigators","volume":"29","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"key20260629115258_B67","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.hrthm.2010.03.036","article-title":"Relationship between burden of premature ventricular complexes and left ventricular function","volume":"7","year":"2010","journal-title":"Heart Rhythm"},{"key":"key20260629115258_B68","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jacc.2013.06.012","article-title":"Neurohormonal, structural, and functional recovery pattern after premature ventricular complex ablation is independent of structural heart disease status in patients with depressed left ventricular ejection fraction: a prospective multicenter study","volume":"62","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key20260629115258_B69","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.hrthm.2015.09.011","article-title":"Ablation of frequent PVC in patients meeting criteria for primary prevention ICD implant: safety of withholding the implant","volume":"12","year":"2015","journal-title":"Heart Rhythm"},{"key":"key20260629115258_B70","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1093\/eurheartj\/ehae345","article-title":"Loop diuretic therapy with or without heart failure: impact on prognosis","volume":"45","year":"2024","journal-title":"Eur Heart J"},{"key":"key20260629115258_B71","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"ESC Scientific Document Group","year":"2024","journal-title":"Eur Heart J"}],"container-title":["Global Heart"],"original-title":[],"link":[{"URL":"https:\/\/globalheartjournal.com\/articles\/1569\/files\/6a421ef044e0f.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/globalheartjournal.com\/articles\/1569\/files\/6a421ec53eb6d.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/globalheartjournal.com\/articles\/1569\/files\/6a421eb29c234.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:07:42Z","timestamp":1782734862000},"score":1,"resource":{"primary":{"URL":"https:\/\/globalheartjournal.com\/articles\/10.5334\/gh.1569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,14]]}},"URL":"https:\/\/doi.org\/10.5334\/gh.1569","relation":{},"ISSN":["2211-8179","2211-8160"],"issn-type":[{"value":"2211-8179","type":"electronic"},{"value":"2211-8160","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}